Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial - Kobbernagel, H E; Buchvald, F F; Haarman, E G (Lancet Respir Med, 2020)
et al.